Palisade Bio Receives FDA Clearance For Its Investigational New Drug Application For PALI-2108 To Treat Crohn's Disease; First Participant Enrollment Anticipated In Q1 Next Year

Benzinga

2026.09.22 12:36 (GMT+0)

Benzingaで開く